CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 18:44 UTC

The Annexure

Desk Healthcare Thyrocare Technologies Ltd

Thyrocare Technologies Ltd

BSE 539871 THYROCARE INE594H01019
Healthcare Healthcare Healthcare Services Healthcare Service Provider

Filing rhythm · 61 trading days

39 filings · 5 material · busiest 2026-07-23

What it files

Filings

39 in the window

  1. 19 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  2. 19 August 2026

    Other Update

    Disclosure under Regulation 30A of LODR

    Please find enclosed the Intimation regarding complete discharge and release of Transaction Documents pursuant to full redemption and repayment of Non-Convertible Debentures by API Holdings Limited

    Others View filing →

  3. 18 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PAC

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  4. 18 August 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 13, 2026 for Docon Technologies Pvt Ltd

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  5. 18 August 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HSBC Mutual Fund

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  6. 18 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  7. 18 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  8. 17 August 2026

    General

    Communication Received From Promoter Regarding Release Of Pledge On Equity Shares Of Thyrocare Technologies Limited

    Please refer the enclosed intimation letter

    Company Update / General View filing →

  9. 17 August 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 17, 2026 for Docon Technologies Pvt Ltd

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  10. 14 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  11. 14 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  12. 13 August 2026

    General

    Communication Received From Promoter Regarding Release Of Pledge On 1,75,00,000 Equity Shares Of Thyrocare Technologies Limited

    Please find the attached disclosure received from Docon Technologies Private Limited ("Promoter") for release of pledge on equity shares of the Company

    Company Update / General View filing →

  13. 13 August 2026

    General

    Communication Received From Promoter Regarding Sale Of 1,57,69,696 Equity Shares Of The Company By Promoter - Docon Technologies Private Limited.

    Please refer the enclosed intimation letter.

    Company Update / General View filing →

  14. 13 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  15. 13 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  16. 27 July 2026

    Concall Transcript

    Earnings Call Transcript

    Please find attached the Earnings Call Transcript held on July 23, 2026

    Company Update / Earnings Call Transcript View filing →

  17. 24 July 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached herewith Newspaper Publication of Unaudited Financial Results for the quarter ended on June 30, 2026

    Company Update / Newspaper Publication View filing →

  18. 24 July 2026

    General

    Submission Of Machine-Readable Document Of Earlier Submitted Results Of The Company For The Quarter Ended On June 30, 2026

    Thyrocare Technologies Limited has informed the exchange regarding submission of machine-readable document of earlier submitted results of the Company for the quarter ended on June 30, 2026

    Company Update / General View filing →

  19. 23 July 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Held On July 23, 2026

    Please find enclosed outcome of the Board Meeting held on July 23, 2026, inter alia, approving the unaudited financial results for the quarter ended June 30, 2026, as detailed in the enclosed letter.

    Board Meeting / Outcome of Board Meeting View filing →

  20. 23 July 2026

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026

    Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2026

    Result / Financial Results View filing →

  21. 23 July 2026

    Press Release

    Press Release / Media Release

    Please find attached the Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30, 2026

    Company Update / Press Release / Media Release View filing →

  22. 23 July 2026

    Investor Presentation

    Investor Presentation

    Please find attached the Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30, 2026

    Company Update / Investor Presentation View filing →

  23. 23 July 2026

    General

    Re-Appointment Of Internal Auditor Of The Company

    Please find attached the Intimation regarding the re-appointment of the Internal Auditor of the Company.

    Company Update / General View filing →

  24. 23 July 2026

    General

    Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please refer the enclosed intimation regarding the in-principle approval of the Board of Directors of the Company for evaluation of the proposed restructuring of the radiology business ....

    Company Update / General View filing →

  25. 23 July 2026

    General

    Audio Recording Of Earnings Conference Call For The Quarter Ended June 30, 2026

    Audio Recording of Earnings Conference Call for the quarter ended on June 30, 2026

    Company Update / General View filing →

  26. 16 July 2026

    Board Meeting

    Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026

    Thyrocare Technologies Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve Unaudited Standalone ....

    Board Meeting / Board Meeting View filing →

  27. 16 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Thyrocare Technologies Limited cordially invites you to its "Earning Call" to be held on Thursday, July 23, 2026 at 06.00 P.M. to discuss the financial performance of the company for Q1 FY27.

    Company Update / Analyst / Investor Meet View filing →

  28. 7 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find attached herewith Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  29. 30 June 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 26th Annual General Meeting held on 30th June, 2026. Further the scrutinizer's report along with voting results is enclosed.

    AGM/EGM / AGM View filing →

  30. 30 June 2026

    General

    Change In Statutory Auditors Of The Company

    Please find enclosed intimation regarding change in Statutory Auditors of the Company

    Company Update / General View filing →

  31. 30 June 2026

    Charter Amendment

    Amendments to Memorandum & Articles of Association

    Please find enclosed intimation regarding Amendments to Memorandum of Association of the Company.

    Company Update / Amendments to Memorandum & Articles of Association View filing →

  32. 24 June 2026

    Trading Window

    Closure of Trading Window

    Please find attached the Intimation for Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  33. 10 June 2026

    General

    Communication To Shareholders - Intimation On Tax Deduction On Dividend

    Please find enclosed communication sent to shareholders for deduction of tax on dividend.

    Company Update / General View filing →

  34. 5 June 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached herewith copies of Newspaper Publications published on June 05, 2026, in Business Standard (English) and Navshakti (Marathi)

    Company Update / Newspaper Publication View filing →

  35. 4 June 2026

    AGM / EGM

    Notice Of 26Th Annual General Meeting Of Thyrocare Technologies Limited To Be Held On Tuesday, June 30, 2026 At 11:00 A.M. (IST)

    Please find attached the Notice of 26th Annual General Meeting along with Annual Report for the FY 2025-26.

    AGM/EGM / AGM View filing →

  36. 4 June 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Please find attached the Annual Report of Thyrocare Technologies Limited for the FY 2025-26.

    Others / Reg. 34 (1) Annual Report View filing →

  37. 4 June 2026

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Please find attached the Business Responsibility and Sustainability Reporting (BRSR) of the Company for the FY 2025-26

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  38. 4 June 2026

    Record Date

    Record Date For The Purpose Of Final Dividend For The FY 2025-26 Is Tuesday, June 23, 2026

    Please find attached intimation of Record Date for the purpose of final dividend for the FY 2025-26.

    Corp. Action / Record Date View filing →

  39. 4 June 2026

    General

    Letter Sent To Members Of The Company Providing Web Link For AGM Notice And Annual Report For The FY 2025-26

    Please find attached letter sent to members of the Company providing web link for the AGM Notice and Annual report for the FY 2025-26

    Company Update / General View filing →